InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
60%
T+90 mean return
+18.6%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Fisher Stewart, Directeur Scientifique. Insider active across 1 company, notably C4 Therapeutics, Inc.. Cumulatively, 14 filings have been recorded. Split: 0 buy · 4 sells. Total volume traded: €5.1m. Activity tracked since 29 July 2021. The latest transaction was disclosed on 13 February 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations14 total
2,250 sharesCommon StockSEC:0001662579-24-000081:0
2,255 shares@ US$6.530.3% of flowCommon StockSEC:0001662579-24-000016:0
2,250 sharesCommon StockSEC:0001662579-23-000082:0
26,000 shares0Common StockSEC:0001662579-23-000039:0
3,750 sharesCommon StockSEC:0001662579-23-000018:0
1,102 shares@ US$7.010.0039% mcap0.1% of flowCommon StockSEC:0001209191-22-036715:0
3,750 sharesCommon StockSEC:0001209191-22-032511:0
2,156 shares@ US$3.710.0040% mcap0.1% of flowCommon StockSEC:0001209191-22-024228:0
2,373 shares@ US$2.110.1% of flowCommon StockSEC:0001209191-21-069036
2,373 shares@ US$2.110.0024% mcap0.1% of flowCommon StockSEC:0001209191-21-069036:0
17,057 shares@ US$45.01450.35% mcap12.6% of flowCommon StockSEC:0001209191-21-050055:0
17,057 shares@ US$45.014512.6% of flowCommon StockSEC:0001209191-21-050055
50,211 shares@ US$45.00271.03% mcap37.1% of flowCommon StockSEC:0001209191-21-049116:0
50,211 shares@ US$45.002737.0% of flowCommon StockSEC:0001209191-21-049116
14 of 14 declarations
About Fisher Stewart
Fisher Stewart is the Chief Scientific Officer of C4 Therapeutics, Inc. In this role, he is responsible for leading research and development of new treatments. His expertise in biotechnology is essential for guiding the company towards innovation. Stewart works closely with research teams to develop advanced therapeutic solutions.
